-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on FibroBiologics, Maintains $15 Price Target

Benzinga·01/06/2026 14:42:37
語音播報
D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $15 price target.